Home
About
Overview
Sharing Data
ORCID
Help
History (30)
Cerebrovascular Complications in Early Survivors of Civilian Penetrating Brain Injury
Proteoglycan Synthesis in Mutant Mouse Systems
Childhood Development and the Microbiome-The Intestinal Microbiota in Maintenance of Health and Development of Disease During Childhood Development.
Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.
Assessing treatment benefit with competing risks not affected by the randomized treatment.
See All 30 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Assessing treatment benefit with competing risks not affected by the randomized treatment.
Assessing treatment benefit with competing risks not affected by the randomized treatment. Stat Med. 2015 Jan 30; 34(2):265-80.
View in:
PubMed
subject areas
Cause of Death
Early Detection of Cancer
Epidemiologic Research Design
Humans
Kaplan-Meier Estimate
Male
Prostatic Neoplasms
Quality-Adjusted Life Years
Randomized Controlled Trials as Topic
Risk Assessment
Time Factors
authors with profiles
James Dignam